Catherine M. Tangen
- Geriatrics and Gerontology top 0.01%
- Pulmonary and Respiratory Medicine top 0.02%
- Prostate Cancer Treatment and Research 135
- Prostate Cancer Diagnosis and Treatment 87
- Renal cell carcinoma treatment 21
- Physiology top 0.05%
- Urology top 0.1%
- Cancer Research top 0.2%
-
- Bladder and Urothelial Cancer Treatments 39
- Urinary and Genital Oncology Studies 21
-
- Statistical Methods in Clinical Trials 28
-
- Hormonal and reproductive studies 26
-
- Radiopharmaceutical Chemistry and Applications 20
- Co-authors
- Jeremy WalstonCalvin H. HirschJohn S. GottdienerWillem J. KopLinda P. FriedAnne B. NewmanRussell P. TracyMary Ann McBurnie
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Catherine M. Tangen
246 papers receiving 37.7k citations
Hit Papers
Peers
Comparison fields: 5 of 195
- Geriatrics and Gerontology 11.0k
- Pulmonary and Respiratory Medicine 14.5k
- Physiology 9.3k
- Urology 2.1k
- Cancer Research 3.4k
Countries citing papers authored by Catherine M. Tangen
This map shows the geographic impact of Catherine M. Tangen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine M. Tangen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine M. Tangen more than expected).
Fields of papers citing papers by Catherine M. Tangen
This network shows the impact of papers produced by Catherine M. Tangen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine M. Tangen. The network helps show where Catherine M. Tangen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Catherine M. Tangen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 7 | |
| 3 | 2023 | 48 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 30 | |
| 7 | 2022 | 1 | |
| 8 | 2022 | 3 | |
| 9 | 2021 | 58 | |
| 10 | 2020 | 7 | |
| 11 | 2020 | 4 | |
| 12 | 2019 | 4 | |
| 13 | 2018 | 2 | |
| 14 | 2016 | 47 | |
| 15 | 2011 | 83 | |
| 16 | 2008 | 140 | |
| 17 | 2007 | 198 | |
| 18 | 2006 | 23 | |
| 19 | 2006 | 217 | |
| 20 | Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancerbreakdown → | 2003 | 1834 |
About Catherine M. Tangen
Catherine M. Tangen is a scholar working on Pulmonary and Respiratory Medicine, Statistics and Probability and Cancer Research, having authored 254 papers that have together received 38.7k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (135 papers), Prostate Cancer Diagnosis and Treatment (87 papers), Bladder and Urothelial Cancer Treatments (39 papers), Statistical Methods in Clinical Trials (28 papers), Hormonal and reproductive studies (26 papers), Renal cell carcinoma treatment (21 papers), Urinary and Genital Oncology Studies (21 papers) and Radiopharmaceutical Chemistry and Applications (20 papers). The work is most often cited by research in Geriatrics and Gerontology (11.0k citations), Pulmonary and Respiratory Medicine (14.5k citations) and Physiology (9.3k citations). Catherine M. Tangen has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Jeremy Walston, Calvin H. Hirsch, John S. Gottdiener, Willem J. Kop, Linda P. Fried, Anne B. Newman, Russell P. Tracy, Mary Ann McBurnie, Teresa E. Seeman and Gregory L. Burke. Their work appears in journals such as New England Journal of Medicine, The Lancet and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.